BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32455810)

  • 1. Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs.
    Nakayama J; Makinoshima H
    Molecules; 2020 May; 25(10):. PubMed ID: 32455810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic cancer drug using the zebrafish model.
    Santoro MM
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1846-53. PubMed ID: 24903092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A zebrafish embryo screen utilizing gastrulation identifies the HTR2C inhibitor pizotifen as a suppressor of EMT-mediated metastasis.
    Nakayama J; Tan L; Li Y; Goh BC; Wang S; Makinoshima H; Gong Z
    Elife; 2021 Dec; 10():. PubMed ID: 34919051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model.
    Lee SL; Rouhi P; Dahl Jensen L; Zhang D; Ji H; Hauptmann G; Ingham P; Cao Y
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19485-90. PubMed ID: 19887629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological strategies and micrometastasis: what is known? What must be done?
    Perret GY
    Minerva Med; 2010 Jun; 101(3):163-78. PubMed ID: 20562804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish xenograft models of cancer and metastasis for drug discovery.
    Brown HK; Schiavone K; Tazzyman S; Heymann D; Chico TJ
    Expert Opin Drug Discov; 2017 Apr; 12(4):379-389. PubMed ID: 28277839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in the development of anti-tumor metastatic drugs].
    Kumagai H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):585-91. PubMed ID: 7536403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
    Yang X; Cui W; Yu S; Xu C; Chen G; Gu A; Li T; Cui Y; Zhang X; Bian X
    PLoS One; 2014; 9(1):e85759. PubMed ID: 24454929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array (HMCA)-based Plates.
    Ravid-Hermesh O; Zurgil N; Shafran Y; Afrimzon E; Sobolev M; Hakuk Y; Bar-On Eizig Z; Deutsch M
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced metastasis model in embryonic zebrafish.
    Rouhi P; Jensen LD; Cao Z; Hosaka K; Länne T; Wahlberg E; Steffensen JF; Cao Y
    Nat Protoc; 2010 Dec; 5(12):1911-8. PubMed ID: 21127485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dianhydrogalactitol, a potential multitarget agent, inhibits glioblastoma migration, invasion, and angiogenesis.
    Jiang X; Huang Y; Wang X; Liang Q; Li Y; Li F; Fu X; Huang C; Liu H
    Biomed Pharmacother; 2017 Jul; 91():1065-1074. PubMed ID: 28525947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy.
    Gunjal PM; Schneider G; Ismail AA; Kakar SS; Kucia M; Ratajczak MZ
    J Ovarian Res; 2015 Mar; 8():20. PubMed ID: 25887079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical assessment of anti-cancer therapeutic strategies using in vivo videomicroscopy.
    Chambers AF; MacDonald IC; Schmidt EE; Morris VL; Groom AC
    Cancer Metastasis Rev; 1998-1999; 17(3):263-9. PubMed ID: 10352879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal-mode migration assay and antimetastatic drug screening with high-throughput microfluidic channel networks.
    Zhang Y; Zhang W; Qin L
    Angew Chem Int Ed Engl; 2014 Feb; 53(9):2344-8. PubMed ID: 24478127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model.
    Reddy VG; Reddy TS; Jadala C; Reddy MS; Sultana F; Akunuri R; Bhargava SK; Wlodkowic D; Srihari P; Kamal A
    Eur J Med Chem; 2019 Nov; 182():111609. PubMed ID: 31445229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk.
    Tobia C; Gariano G; De Sena G; Presta M
    Biochim Biophys Acta; 2013 Sep; 1832(9):1371-7. PubMed ID: 23357577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products as anti-invasive and anti-metastatic agents.
    Jiang YL; Liu ZP
    Curr Med Chem; 2011; 18(6):808-29. PubMed ID: 21182481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.